<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37087708</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-6692</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Herz</Title><ISOAbbreviation>Herz</ISOAbbreviation></Journal><ArticleTitle>A&#xa0;practical approach for the treatment of post-COVID symptoms.</ArticleTitle><Pagination><StartPage>243</StartPage><EndPage>246</EndPage><MedlinePgn>243-246</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00059-023-05177-3</ELocationID><Abstract><AbstractText>For the past 3&#xa0;years, our daily lives have been largely dictated by the coronavirus disease 2019 (COVID-19) pandemic. In many people, this infectious disease leads to long-lasting symptoms, which can vary greatly in form and intensity between individuals. This report describes the case of a&#xa0;young patient who had no health restrictions until she came into contact with severe acute respiratory syndrome coronavirus&#xa0;2 (SARS-CoV-2). As part of a&#xa0;post-COVID syndrome, she not only temporarily lost her ability to work, but was also no longer able to manage her daily life independently. A&#xa0;crucial therapeutic approach, in this case, was the use of heparin-induced extracorporeal LDL/fibrinogen precipitation (H.E.L.P.) apheresis.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heitmann</LastName><ForeName>Juliane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldudak</LastName><ForeName>S&#xfc;meya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schieffer</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schieffer</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;fer</LastName><ForeName>Ann-Christin</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology, and Intensive Care Medicine, Philipps University of Marburg, Baldinger Str., 35043, Marburg, Germany. ann-christin.schaefer@uk-gm.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Praktischer Ansatz zur Behandlung von Post-COVID-Symptomen.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Herz</MedlineTA><NlmUniqueID>7801231</NlmUniqueID><ISSNLinking>0340-9937</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Die letzten 3&#xa0;Jahre wurde unser Alltag ma&#xdf;geblich durch die COVID-19-Pandemie (Coronavirus Disease 2019) diktiert. Bei einer gro&#xdf;en Zahl an Menschen f&#xfc;hrt diese Infektionserkrankung zu langanhaltenden Beschwerden, welche interindividuell sehr stark in ihrer Form und Intensit&#xe4;t variieren k&#xf6;nnen. Im vorliegenden Fallbericht wird &#xfc;ber eine junge Patientin berichtet, die bis zum Kontakt mit SARS-CoV&#x2011;2 (Severe Acute Respiratory Syndrome Coronavirus&#xa0;2) keine gesundheitlichen Einschr&#xe4;nkungen auswies und im Rahmen eines Post-COVID-Syndroms nicht nur ihre Arbeitsf&#xe4;higkeit tempor&#xe4;r verloren hat, sondern auch ihren Alltag nicht mehr selbstst&#xe4;ndig bew&#xe4;ltigen konnte. Ein entscheidender Therapieansatz war in diesem Fall der Einsatz der H.E.L.P.-Apherese (heparininduzierte extrakorporale LDL-Pr&#xe4;zipitation).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID 19</Keyword><Keyword MajorTopicYN="N">Chronic condition</Keyword><Keyword MajorTopicYN="N">H.E.L.P. apheresis</Keyword><Keyword MajorTopicYN="N">Hyperlipoproteinemia</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>J.&#xa0;Heitmann, J.&#xa0;Kreutz,S.&#xa0;Aldudak, E.&#xa0;Schieffer, B.&#xa0;Schieffer and A.-C.&#xa0;Sch&#xe4;fer declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>23</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>23</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37087708</ArticleId><ArticleId IdType="pmc">PMC10122758</ArticleId><ArticleId IdType="doi">10.1007/s00059-023-05177-3</ArticleId><ArticleId IdType="pii">10.1007/s00059-023-05177-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koc HC, Xiao J, Liu W, et al. Long COVID and its management. Int J Biol Sci. 2022;18(12):4768&#x2013;4780. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM. Long COVID: major findings, mechanisms, and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386&#x2013;401. doi: 10.1111/imm.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13443</ArticleId><ArticleId IdType="pubmed">34957554</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hasan SS. The association between the use of statins and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. Am J Cardiovasc Drugs. 2022;22(2):167&#x2013;181. doi: 10.1007/s40256-021-00490-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-021-00490-w</ArticleId><ArticleId IdType="pmc">PMC8328743</ArticleId><ArticleId IdType="pubmed">34341972</ArticleId></ArticleIdList></Reference><Reference><Citation>Montanari M, Canonico B, Nordi E, et al. Which ones, when, and why should renin-angiotensin system inhibitors work against COVID-19? Adv Biol Regul. 2021;81:100820. doi: 10.1016/j.jbior.2021.100820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2021.100820</ArticleId><ArticleId IdType="pmc">PMC8359569</ArticleId><ArticleId IdType="pubmed">34419773</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S, Harb J, Rima M, et al. The pathophysiology of long COVID throughout the Renin-Angiotensin system. Molecules. 2022;27(9):2903. doi: 10.3390/molecules27092903.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, et al. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70(1):61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto MD, Lambert N, Downs CA, et al. Antihistamines for postacute sequelae of SARS-coV-2 infection. J Nurse Pract. 2022;18(3):335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Tselmin S, Julius U, Jarzebska N, et al. COVID-19 and therapeutic Apheresis. Horm Metab Res. 2022;54(8):571&#x2013;577. doi: 10.1055/a-1864-9482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1864-9482</ArticleId><ArticleId IdType="pubmed">35944525</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Walther R, Tselmin S, et al. Post COVID and Apheresis&#x2014;where are we standing? Horm Metab Res. 2022;54(11):715&#x2013;720. doi: 10.1055/a-1945-9694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1945-9694</ArticleId><ArticleId IdType="pubmed">36113501</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidel D. H.E.L.P. apheresis therapy in the treatment of severe hypercholesterolemia: 10&#xa0;years of clinical experience. Artif Organs. 1996 doi: 10.1111/j.1525-1594.1996.tb04449.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1594.1996.tb04449.x</ArticleId><ArticleId IdType="pubmed">8860711</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR et al (2022) S1-Leitlinie Long/ Post-COVID (Stand17.08.2022), AWMF-Registernummer: 020-027. https://register.awmf.org/de/leitlinien/detail/020-027. Accessed 2 Mar 2023</Citation></Reference><Reference><Citation>Schieffer E, Schieffer B. The rationale for the treatment of long-Covid symptoms&#x2014;a cardiologist&#x2019;s view. Front Cardiovasc Med. 2022;15(9):992686. doi: 10.3389/fcvm.2022.992686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.992686</ArticleId><ArticleId IdType="pmc">PMC9520195</ArticleId><ArticleId IdType="pubmed">36186977</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>